Table 1.
Author | Year | Country | Micromotion OI (µm) | Micromotion Non-OI (µm) | Applied or measured | Animal or Human |
---|---|---|---|---|---|---|
Aspenberg32 | 1992 | Sweden | N/A | 500 | Applied | Animal |
Bragdon33 | 1996 | USA | 20 | 40,150 | ||
Duyck34 | 2006 | Belgium | 60 | 30,90 | ||
Goodman a35 | 1995 | USA | N/A | 500,500 | ||
Goodman b31 | 1993 | Sweden | 750 | 750 | ||
Goodman c36 | 1994 | Sweden | 500*0 | 500 | ||
Goodman d37 | 1993 | Sweden | 500 | 500 | ||
Jakobsen a 38 | 2015 | Denmark | N/A | 500 | ||
Jakobsen b39 | 2017 | Denmark | N/A | 500,500 | ||
Jasty40 | 1997 | USA | 20 | 40,150 | ||
Kawahara29 | 2003 | Japan | 30 | 580,630 | ||
Overgaard41 | 1996 | Denmark | 150*0 | 150 *12 | ||
Soballe a42 | 1992 | Denmark | N/A | 500,500 | ||
Soballe b43 | 1992 | Denmark | 150 | 150 | ||
Vandamme a30 | 2007 | Belgium | 30,50 | 30 | ||
Vandamme b44 | 2007 | Belgium | 30,90 | N/A | ||
Vandamme c45 | 2008 | Belgium | 30,30 | N/A | ||
Vandamme d46 | 2007 | Belgium | 30,30 | N/A | ||
Manley25 | 1995 | USA | 33 ± 23.7, 17 ± 4.2 | N/A | Measured | |
Pilliar47 | 1986 | Canada | 28 | 150 | ||
Trisi a48 | 2017 | Italy | 77.9 ± 17.29, 75.3 ± 19 | N/A | ||
Trisi b8 | 2015 | Italy | 64 ± 27 | 177 ± 87 | ||
15 ± 5 ,22 ± 6 | N/A | |||||
Trisi c49 | 2016 | Italy | 94.88 ± 10.94, 60.45 ± 5.29 | N/A | ||
Trisi d50 | 2016 | Italy | 161.26 ± 134.39 | 619.5 ± 328.26 | ||
Engh51 | 1992 | USA | < 40 | 150 | Measured | Human |
For applied values, the value was set as a controlled experimental parameter, for measured values means and standard deviation are reported where possible. *0 represents experiments with immobilized implants after a period of loading. *12 represents experiments that applied an additional implant displacement for 12 weeks.